HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgREGISTER
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

No approved articles at present.


View all articles
Submit an article
Thrombosis risk may be raised by cancer drugs
Cancer patients receiving drugs to lower the risk of anaemia may be...
Published Tuesday 01 December 2009

Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have undergone chemotherapy....
Published Tuesday 01 December 2009

Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a regular basis...
Published Monday 30 November 2009

Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more likely to...
Published Sunday 29 November 2009

Number of Americans with diabetes expected to double by 2034
The number of people developing diabetes in the US is expected to...
Published Sunday 29 November 2009

H1N1 virus appears to increase asthma risk in children
Asthma is a significant risk factor in children who have contracted the...
Published Sunday 29 November 2009

New treatment could prevent thrombosis in PAD patients
Thrombosis is a common side effect in patients undergoing bypass surgery for...
Published Sunday 29 November 2009

More Medical News
Opioid and Pain Management - understanding, management, diagnosis and treatment information The term “isolated systolic hypertension” (ISH) describes raised systolic blood pressure with normal or low diastolic blood pressure. Some guidelines recognise two grades of isolated systolic hypertension: Lysosomal storage disorders (LSDs) are a group of progressive and often fatal genetic diseases that are caused by an inborn error of metabolism Cystic Fibrosis
More Medical NewsMen's Health Medical News

Erectile dysfunction drug can benefit heart disease patients

19 Nov 2009 - Posted by the Editorial Team

A drug used for men with erectile dysfunction has been found to improve heart function in individuals with single-ventricle congenital heart disease.

Researchers at The Children's Hospital of Philadelphia, US, said that heart function is "significantly improved" in both children and young adults with the disease who have had the Fontan operation after treatment with sildenafil, which is also used to treat pulmonary hypertension.

Examples of single-ventricle defects include tricuspid atresia, pulmonary atresia/intact ventricular septum and hypoplastic left heart syndrome, all of which adversely affect the heart's ability to pump blood.

It is believed that sildenafil may boost cardiac performance by directly improving the squeeze of the heart muscle and allowing for better filling of the heart.

Paediatric cardiologist Dr David Goldberg concluded: "The enhanced heart performance may improve exercise performance and quality of life in these children and young adults."

Sildenafil was developed by Pfizer and is sold under various brand names including Viagra and Revatio.

It became available in 1998 and is now the prime treatment for erectile dysfunction.

Visit the Men's Health Knowledge CentreADNFCR-1419-ID-19468053-ADNFCR

Print Article    Bookmark Bookmark
Related Men's Health News
More Drugs Latest Drugs

Soft Tissue Sarcoma In Focus

Soft Tissue Sarcoma

DRUG UPDATES Drug updates feed

HEALTH JOBS

Latest healthcare vacancies for a variety of medical specialties

Visit The Latest EPG Health Jobs

CONNECT

DISEASE CENTRES Disease Centres feed

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed